Stock Research for BIOYF

BIOYF

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

BIOYF Stock Chart & Research Data

The BIOYF chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the BIOYF chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


BIOYF Due diligence Resources & Stock Charts

The BIOYF stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View BIOYF Detailed Price Forecast - CNN Money CNN View BIOYF Detailed Summary - Google Finance
Yahoo View BIOYF Detailed Summary - Yahoo! Finance Zacks View BIOYF Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View BIOYF Trends & Analysis - Trade-Ideas Barrons View BIOYF Major Holders - Barrons
NASDAQ View BIOYF Call Transcripts - NASDAQ Seeking View BIOYF Breaking News & Analysis - Seeking Alpha
Spotlight View BIOYF Annual Report - CompanySpotlight.com OTC Report View BIOYF OTC Short Report - OTCShortReport.com
TradeKing View BIOYF Fundamentals - TradeKing Charts View BIOYF SEC Filings - Bar Chart
WSJ View Historical Prices for BIOYF - The WSJ Morningstar View Performance/Total Return for BIOYF - Morningstar
MarketWatch View the Analyst Estimates for BIOYF - MarketWatch CNBC View the Earnings History for BIOYF - CNBC
StockMarketWatch View the BIOYF Earnings - StockMarketWatch MacroAxis View BIOYF Buy or Sell Recommendations - MacroAxis
Bullish View the BIOYF Bullish Patterns - American Bulls Short Pains View BIOYF Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View BIOYF Stock Mentions - StockTwits PennyStocks View BIOYF Stock Mentions - PennyStockTweets
Twitter View BIOYF Stock Mentions - Twitter Invest Hub View BIOYF Investment Forum News - Investor Hub
Yahoo View BIOYF Stock Mentions - Yahoo! Message Board Seeking Alpha View BIOYF Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for BIOYF - SECform4.com Insider Cow View Insider Transactions for BIOYF - Insider Cow
CNBC View BIOYF Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for BIOYF - OTC Markets
Yahoo View Insider Transactions for BIOYF - Yahoo! Finance NASDAQ View Institutional Holdings for BIOYF - NASDAQ


Stock Charts

FinViz View BIOYF Stock Insight & Charts - FinViz.com StockCharts View BIOYF Investment Charts - StockCharts.com
BarChart View BIOYF Stock Overview & Charts - BarChart Trading View View BIOYF User Generated Charts - Trading View




Latest Financial News for BIOYF


BioSyent to Attend Planet MicroCap Showcase
Posted on Tuesday April 23, 2024

MISSISSAUGA, Ontario, April 23, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be attending the Planet MicroCap Showcase in Las Vegas, Nevada between April 30th – May 2nd at the Paris Hotel & Casino. Mr. René Goehrum, President and CEO of BioSyent, will attend a Fireside Q&A session for investors at the conference on Wednesday, May 1st at 2:30pm PDT. Mr. Goehrum will also be available to meet with investors on a one-on-one basis during th


BioSyent Announces Extension of RepaGyn® and Proktis-M® Agreement
Posted on Monday April 15, 2024

MISSISSAUGA, Ontario, April 15, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has extended its Exclusive License and Distribution Agreement with its European partner for the RepaGyn® and Proktis-M® products, extending BioSyent Pharma’s exclusive Canadian rights to these products until 2032. “RepaGyn® and Proktis-M® have been part of our product portfolio since


BioSyent to Present at 2024 Bloom Burton & Co. Healthcare Investor Conference
Posted on Wednesday April 10, 2024

MISSISSAUGA, Ontario, April 10, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it will be presenting at the upcoming 2024 Bloom Burton & Co. Healthcare Investor Conference. The conference will be held in Toronto at the Metro Toronto Convention Centre (North Building) on Tuesday, April 16 and Wednesday, April 17, 2024. Mr. René Goehrum, President and CEO of BioSyent, will present to investors an overview of BioSyent’s business and corporate activi


FeraMAX® Named #1 Recommended Iron Supplement in Canada by Pharmacists and Physicians for Ninth Consecutive Year
Posted on Wednesday April 03, 2024

MISSISSAUGA, Ontario, April 03, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that FeraMAX® is the #1 recommended iron supplement brand in Canada, based on a national survey of Canadian pharmacists and physicians(1). This year marks the ninth consecutive year that FeraMAX® has been awarded this vote of confidence from physicians and pharmacists across Canada, including those professionals in Quebec. The annual Survey on OTC Counselling and Recommenda


Stock Market & Investing Books

Enter a stock symbol to view the stock details.